KreutzburgTPetersFKuchenbeckerJ, et al.Editor's choice-the GermanVasc score: a pragmatic risk score predicts five year amputation free survival in patients with peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg. 2021;61:248-256.
2.
Baubeta FridhEAnderssonMThuressonM, et al.Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study. Eur J Vasc Endovasc Surg. 2017;54:480-486.
3.
StoberockKKaschwichMNicolaySS, et al.The interrelationship between diabetes mellitus and peripheral arterial disease. Vasa. 2021;50:323-330.
4.
O'NeillWCHanKHSchneiderTMHennigarRA. Prevalence of nonatheromatous lesions in peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2015;35:439-47.
5.
LapebieFXBongardVLacroixP, et al.Mortality, cardiovascular and limb events in patients with symptomatic lower extremity artery disease and diabetes. Angiology. 2022;73:528-538.
6.
LuanJXuJZhongWZhouYLiuHQianK. Adverse prognosis of peripheral artery disease treatments associated with diabetes: a comprehensive meta-analysis. Angiology. 2022;73(4):318-330.
BehrendtC-ASigvantBKuchenbeckerJ, et al.Editor's choice-international variations and sex disparities in the treatment of peripheral arterial occlusive disease: a report from VASCUNET and the international consortium of vascular registries. Eur J Vasc Endovasc Surg. 2020;60:873-880.
9.
RodionovRNPetersFMarschallUL’HoestHJarzebskaNBehrendtC-A. Initiation of SGLT2 inhibitors and the risk of lower extremity minor and major amputation in patients with type 2 diabetes and peripheral arterial disease: a health claims data analysis. Eur J Vasc Endovasc Surg. 2021;62:981-990.
